Your English writing platform
Discover LudwigSuggestions(1)
Exact(4)
After treatment, three out of 13 (23.1 %) patients had reported complete resolution of bone pain and eight (61.5%%) reported a decrease in pain severity.
6, 15, 20 The study by Goldstein et al included a duloxetine 20 mg once-a-day treatment group, and found that this group had a nonsignificant decrease in pain severity compared to placebo.
Therapeutic efficacy was demonstrated (1) by symptom relief and (2) by a decrease in PSA values: out of 13 patients with bone pain, three patients had no pain and eight had a decrease in pain severity after therapy.
A single intra-articular injection of botulinum toxin was associated with a clinically and statistically significant decrease in pain severity and improvement in function compared to baseline: lower extremity and shoulder pain decreased from 7 to 2.7 and 8.2 to 2.4, respectively; shoulder flexion improved from 68 to 113 degrees and shoulder abduction improved from 50 to 74 degrees, respectively.
Similar(56)
Relief from pain was indicated by a significant decrease (P<0.001) in pain severity (decreased visual analog scale scores) and decreases in the frequency of pain (fewer participants reporting permanent frequent pain).
Among those being treated for chronic pain, patients reported significant decreases in pain severity and a one-third reduction in how much their pain interfered with their quality of life.
In another study, 32 statin-treated patients with myopathic symptoms were treated with either 100 mg/day CoQ10 or 400 IU/day vitamin E. A decrease of 40% in pain severity and 38% in pain interference with daily activities was found in the CoQ10 group, while there was no difference in the vitamin E group (23).
Three patients experienced no change in pain severity after botulinum toxin injections, while eight experienced a decrease.
Their results indicated that early treatment reductions in pain helplessness (a dimension of catastrophizing) predicted later treatment decreases in pain and interference, and early treatment reductions in catastrophizing and pain-related anxiety preceded later treatment improvements in pain severity, but not vice versa [ 19].
At follow-up cycle 1, the peak-pain score in the FAD group decreased 2.14 cm and 33.9%, meeting the minimum requirement of 1.3 cm and 33%, respectively, for clinical significance with respect to a change in pain severity [25] [26].
Changes in pain severity (BPI severity score) are shown in Fig. 1.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com